Key result
Oral sotalol successfully converts AF and NSVT to normal sinus rhythm in 2 patients.
Case Report (n=2)
No
A case report discussing the use of oral sotalol for atrial fibrillation conversion and supraventricular tachycardia control.
Does not support practice change; hypothesis-generating for oral sotalol in AF/NSVT and requires randomized confirmation.
Sotalol is a potassium channel inhibitor that also functions as a non-cardio selective beta-blocker. It is a class III agent under the Vaughan-Williams categorization system for antiarrhythmic drugs. It primarily blocks potassium channels. Indications for sotalol include supraventricular tachycardia, hemodynamically stabilized ventricular irregular heartbeat, pharmaceutical cardioversion of atrial fibrillation, preserving sinus rhythm, and surgical atrial fibrillation after heart surgery.
No takes yet. Share an insight, caveat, or question.
Howard B Reinfeld (2023) conducted a case report in Atrial Fibrillation and Supraventricular Tachycardia (n=2). Oral Sotalol was evaluated on Arrhythmia control and conversion to normal sinus rhythm. Oral sotalol effectively controlled arrhythmias and converted atrial fibrillation and non-sustained ventricular tachycardia to normal sinus rhythm in two patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: